Anne Marie Falk

Array ( [id] => 5848678 [patent_doc_number] => 20020133832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Model systems for neuordegenerative and cardiovascular disorders' [patent_app_type] => new [patent_app_number] => 10/052589 [patent_app_country] => US [patent_app_date] => 2002-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 7993 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20020133832.pdf [firstpage_image] =>[orig_patent_app_number] => 10052589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761358 [patent_doc_number] => 20030124720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Conditioned culture media' [patent_app_type] => new [patent_app_number] => 10/038279 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7686 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124720.pdf [firstpage_image] =>[orig_patent_app_number] => 10038279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6760734 [patent_doc_number] => 20030124095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex' [patent_app_type] => new [patent_app_number] => 10/039078 [patent_app_country] => US [patent_app_date] => 2001-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5380 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124095.pdf [firstpage_image] =>[orig_patent_app_number] => 10039078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634008 [patent_doc_number] => 08012456 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => 'Biological models capable of exhibiting secondary disease manifestations and useful for developing therapeutic drugs, diagnostic products and therapeutic or diagnostic procedures, methods of using same, and cells, tissues and organs derived therefrom' [patent_app_type] => utility [patent_app_number] => 10/042711 [patent_app_country] => US [patent_app_date] => 2001-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 6233 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/012/08012456.pdf [firstpage_image] =>[orig_patent_app_number] => 10042711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5858516 [patent_doc_number] => 20020122795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'Compositions containing gangliosides for use in the treatment of skin disorders' [patent_app_type] => new [patent_app_number] => 10/013788 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2759 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20020122795.pdf [firstpage_image] =>[orig_patent_app_number] => 10013788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818237 [patent_doc_number] => 20030069195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Suppression of polymorphic alleles' [patent_app_type] => new [patent_app_number] => 10/000773 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 30502 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069195.pdf [firstpage_image] =>[orig_patent_app_number] => 10000773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6486360 [patent_doc_number] => 20020152491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Methods and transgenic mouse model for identifying and modulating factors leading to motor neuron degeneration' [patent_app_type] => new [patent_app_number] => 09/994420 [patent_app_country] => US [patent_app_date] => 2001-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12213 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20020152491.pdf [firstpage_image] =>[orig_patent_app_number] => 09994420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7436199 [patent_doc_number] => 20040002466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Targeted delivery of genes encoding interferon' [patent_app_type] => new [patent_app_number] => 09/994425 [patent_app_country] => US [patent_app_date] => 2001-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9534 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002466.pdf [firstpage_image] =>[orig_patent_app_number] => 09994425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6432402 [patent_doc_number] => 20020127583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Novel method of detecting and isolating prion protein and variants thereof, and novel methods of diagnosing and treating prion diseases' [patent_app_type] => new [patent_app_number] => 10/035598 [patent_app_country] => US [patent_app_date] => 2001-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9611 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20020127583.pdf [firstpage_image] =>[orig_patent_app_number] => 10035598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6514658 [patent_doc_number] => 20020026042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'Polynucleotide and polypeptide sequence of rabbit G-protein alpha 16' [patent_app_type] => new [patent_app_number] => 09/950960 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7466 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20020026042.pdf [firstpage_image] =>[orig_patent_app_number] => 09950960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 376981 [patent_doc_number] => 07312081 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-25 [patent_title] => 'Genetic demonstration of requirement for nkx6.1, nkx2.2 and nkx6.2 in ventral neuron generation' [patent_app_type] => utility [patent_app_number] => 10/362437 [patent_app_country] => US [patent_app_date] => 2001-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 20 [patent_no_of_words] => 18434 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/312/07312081.pdf [firstpage_image] =>[orig_patent_app_number] => 10362437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6722541 [patent_doc_number] => 20030056231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Development of transgenic model for interventions in neurodegenerative diseases' [patent_app_type] => new [patent_app_number] => 09/933640 [patent_app_country] => US [patent_app_date] => 2001-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8091 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20030056231.pdf [firstpage_image] =>[orig_patent_app_number] => 09933640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6581443 [patent_doc_number] => 20020166132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'System for regulating in vivo the expression of a transgene by conditional inhibition' [patent_app_type] => new [patent_app_number] => 09/931007 [patent_app_country] => US [patent_app_date] => 2001-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 22198 [patent_no_of_claims] => 112 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20020166132.pdf [firstpage_image] =>[orig_patent_app_number] => 09931007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6181997 [patent_doc_number] => 20020157121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Propagation of human hepatocytes in non-human animals' [patent_app_type] => new [patent_app_number] => 09/930781 [patent_app_country] => US [patent_app_date] => 2001-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 27059 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20020157121.pdf [firstpage_image] =>[orig_patent_app_number] => 09930781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6283666 [patent_doc_number] => 20020108136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Transgenic animals produced by homologous sequence targeting' [patent_app_type] => new [patent_app_number] => 09/927160 [patent_app_country] => US [patent_app_date] => 2001-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 36956 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20020108136.pdf [firstpage_image] =>[orig_patent_app_number] => 09927160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921058 [patent_doc_number] => 20020114788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Cell implantation therapy for neurological diseases or disorders' [patent_app_type] => new [patent_app_number] => 09/917126 [patent_app_country] => US [patent_app_date] => 2001-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13030 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20020114788.pdf [firstpage_image] =>[orig_patent_app_number] => 09917126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6142192 [patent_doc_number] => 20020002144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-03 [patent_title] => 'Methods and compositions for bisubstrate inhibitors of acetyltransferases' [patent_app_type] => new [patent_app_number] => 09/910588 [patent_app_country] => US [patent_app_date] => 2001-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8355 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20020002144.pdf [firstpage_image] =>[orig_patent_app_number] => 09910588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 736995 [patent_doc_number] => 07033834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-25 [patent_title] => 'Methods and means for targeted gene delivery' [patent_app_type] => utility [patent_app_number] => 09/901836 [patent_app_country] => US [patent_app_date] => 2001-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10995 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/033/07033834.pdf [firstpage_image] =>[orig_patent_app_number] => 09901836 [rel_patent_id] =>[rel_patent_doc_number] =>)